Association between free fatty acids and vascular calcification in CKD patients

Area of Science:

• Nephrology
• Cardiovascular Medicine
• Biochemistry

Background:

• Vascular calcification (VC) is a significant risk factor for cardiovascular events in chronic kidney disease (CKD) patients.
• Current treatments for VC have limited efficacy, and its underlying mechanisms in CKD remain unclear.
• The association between free fatty acids (FFAs) and VC is established in the general population but not well-studied in CKD patients.

Purpose of the Study:

• To investigate the association between serum FFAs and the severity of vascular calcification in patients with CKD stages 3-4.
• To determine if FFAs are an independent risk factor for vascular calcification in this specific patient group.

Main Methods:

• A cross-sectional study included 103 patients with CKD stages 3-4.
• Vascular calcification severity was assessed using the abdominal aortic calcification score (AACS).
• Logistic regression analyses were performed to evaluate the association between FFAs and AACS, controlling for potential confounders. Receiver operating characteristic (ROC) curves were used to assess the discriminatory ability of FFAs.

Main Results:

• Serum FFAs levels were significantly higher in patients with AACS scores ≥ 5.
• FFAs levels were independently associated with the severity of abdominal aortic calcification (OR=1.269, P=0.012).
• ROC analysis indicated that FFAs had a high discriminatory ability for AAC (AUC=0.868), with optimal threshold at 0.665 mmol/L.

Conclusions:

• Elevated serum FFAs are significantly associated with increased vascular calcification severity in patients with CKD stages 3-4.
• FFAs may represent a potential biomarker or therapeutic target for managing vascular calcification in CKD.
• Further research is warranted to elucidate the causal mechanisms and clinical implications of this association.